Publications

5891 Results

Cetuximab as second-line therapy in patients with metastatic esophageal cancer: a phase II Southwest Oncology Group study

Authors
PJ Gold;B Goldman;S Iqal;LP Leichman;HJ Lenz;CD Blanke
Journal / Conference
Journal of Clinical Oncology 26(15S):222s, #4536
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
S0415

Phase II intergroup study of sorafenib (s) in advanced soft tissue sarcomas (STS) SWOG 0505

Authors
CW Ryan;M von Mehren;C Rankin;JR Goldblum;GD Demetri;VHC Bramwell;EC Borden
Journal / Conference
Journal of Clinical Oncology 26(15S):561s, #10532 (poster)
Year
2008
Research Committee(s)
Sarcoma
Study Number(s)
S0505

Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ), (TT), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508

Authors
JI Clark;J Moon;LF Hutchins;JA Sosman;WM Kast;DM Da Silva;PY Liu;JA Thompson;VK Sondak
Journal / Conference
Journal of Clinical Oncology 26(15S):484s, #9007
Year
2008
Research Committee(s)
Melanoma
Study Number(s)
S0508

Prostate specific antigen progression (PSA-P) as a predictor of overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916

Authors
B Goldman;M Hussain;C Tangen;C Higano;DP Petrylak;N Vogelzang;ED Crawford
Journal / Conference
Proceedings of the American Society of Clinical Oncology 2008 Genitourinary Cancers Symposium, abst. 165
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346, S9916

Pharmacogenetic analysis of stage II/III rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304)

Authors
W Zhang;C Rankin;F Nagashima;CM Ulrich;RS Holmes;KW Makar;JK Benedetti;CD Blanke;SR Smalley;HJ Lenz
Journal / Conference
American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, abst. 300
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (SWOG 9304)

Authors
CM Ulrich;C Rankin;RS Holmes;KW Makar;JK Benedetti;SR Smalley;CD Blanke;HJ Lenz
Journal / Conference
American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, abst. 309, p. 223
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Adjuvant radiotherapy for pT3 for prostate cancer: results of a randomized, prospective clinical trial, 2008 update

Authors
GP Swanson;IM Thompson;C Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;F Miller;MS Lucia;JD Forman;J Chin;EM Messing
Journal / Conference
American Urological Assn Annual Meeting, "late breaking" presentation
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

S0536 SWOG phase II trial of carboplatin (c), paclitaxel (P), cetuximab (CX) and bevacizumab (B) followed by cetuximab and bevacizumab in advanced non-small cell lung cancer (NSCLC)

Authors
ES Kim;RS Herbst;J Moon;J Crowley;M Redman;SR Dakhil;JL Wade;K Kelly;GR Gandara
Journal / Conference
Journal of Thoracic Oncology 3(11) supp. 4:S266, abst. #9
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0536

Identification of genes with abnormal expression changes in acute myeloid leukemia

Authors
DL Stirewalt;S Meshinchi;KJ Kopecky;W Fan;EL Pogosova-Agadjanyan;JH Engel;MR Cronk;KS Dorcy;AR McQuary;D Hockenberry;B Wood;S Heimfeld
Journal / Conference
Genes Chromosomes Cancer 47(1):8-20
Year
2008
Research Committee(s)
Leukemia
PMID
PMID17910043

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group study 0338 [PMID19073506]

Authors
HK Chew;WE Barlow;KS Albain;D Lew;AM Gown;DF Hayes;J Gralow;GN Hortobagyi;R Livingston
Journal / Conference
Clinical Breast Cancer 8(6):511-515
Year
2008
Research Committee(s)
Breast
Study Number(s)
S0338